Studying the lung microbiome requires a specialist approach to sampling, laboratory techniques and statistical analysis. In the latest ERS Monograph, Guest Editors Michael Cox, Markus Ege and Erika von Mutius bring together chapters that introduce the techniques used and discuss how respiratory sampling, 16S rRNA gene sequencing, metagenomics and the application of ecological theory can be used to examine the respiratory microbiome. The book examines the different components of the respiratory microbiome, and considers a range of contexts (from paediatrics to disease at all ages) and respiratory diseases, including asthma, COPD, interstitial lung diseases, cancer and many more.

In “The Lung Microbiome”, the Guest Editors and authors have produced a unique and comprehensive introduction to the field, which will help develop understanding about the concepts and application of this novel area of research.

Book details:
Title: The Lung Microbiome
Guest Editors: Michael J. Cox, Markus J. Ege and Erika von Mutius
Chief Editor: Robert Bals (outgoing), John R. Hurst (incoming)
Print copies available from: www.ersbookshop.com
Print ISBN: 978-1-84984-101-6
Online ISBN: 978-1-84984-102-3

Mit großer Besorgnis verfolgt das Deutsche Zentrum für Lungenforschung (DZL), eines der sechs Deutschen Zentren der Gesundheitsforschung, die derzeitige Diskussion zum Gesundheitsrisiko von Luftschadstoffen. Die DZL-Jahrestagung in Mannheim zum Anlass nehmend, stellt das DZL hinsichtlich seiner Position folgendes fest:

With over 10 million new tuberculosis (TB) cases and 1.6 million deaths, TB is a global health priority. Multidrug-resistant TB is of particular concern to both clinicians and national TB programmes: in 2017, there were 558 000 new rifampicin-resistant cases and 460 000 confirmed multidrug-resistant TB cases. Despite extensive investigation over the years, there is still a great deal to learn about the prevention, diagnosis and treatment of TB.

The latest ERS Monograph on Tuberculosis takes an innovative approach to the disease, beginning with a patients’ perspective chapter. The chapters that follow integrate different views on various aspects of TB, covering: epidemiology; strategies for control and elimination; clinical and laboratory diagnosis; imaging; treatment and drugs; TB in children and different patient populations; comorbidities; and clinical cases.

By bringing together global experts in the field, the book’s Guest Editors, Giovanni Battista Migliori, Graham Bothamley, Raquel Duarte and Adrian Rendon, have produced a Monograph that will not only be useful in the clinical practice of a broad range of respiratory physicians, but will be a trusted resource for many years to come.

Book details:
Title: Tuberculosis
Guest Editors: Giovanni Battista Migliori, Graham Bothamley, Raquel Duarte and Adrian Rendon
Chief Editor: Robert Bals
Print copies available from: www.ersbookshop.com
Print ISBN: 978-1-84984-099-6
Online ISBN: 978-1-84984-100-9

Scientists at Helmholtz Zentrum München, member of the DZL, have now reported a previously unknown pathogenic mechanism... 

Eine assoziierte Partnerschaft des Berliner Instituts für Gesundheitsforschung (BIG) mit dem Deutschen Zentrum für Lungenforschung (DZL) wurde bereits im Jahr 2017 angestoßen und im März 2018 formal vereinbart.

Die Kooperation beinhaltet unter anderem partnerschaftliche Projekte zur translationalen Lungenforschung im Bereich der Cystischen Fibrose. Weitere Kooperationen werden in den Krankheitsbereichen Pulmonale Hypertonie, Pneumonie und Akutes Lungenversagen sowie Asthma und Allergien angestrebt.

Das Berliner Institut für Gesundheitsforschung ist eine Wissenschaftseinrichtung für Translation und Präzisionsmedizin. Es wurde im März 2013 als biomedizinische Forschungseinrichtung von der Charité - Universitätsmedizin Berlin und dem Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC) in Berlin gegründet. Ziel des BIG ist es, Forschungserkenntnisse aus den Lebenswissenschaften schneller und gezielter in für Menschen nützliche medizinische Therapien, Diagnostik und Prävention zu übersetzen und klinische Beobachtungen in die Grundlagenforschung zu transferieren.

Weitere Informationen zum Berliner Institut für Gesundheitsforschung:

https://www.bihealth.org/

Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers...

Marcus Mall is now medical director of the…

DZL Scientists showed that reduced FoxO3 activity reprograms connective tissue cells, triggering the disease...

DZL and DGP have helped to develop and review the German version of the programme…

Nearly half of all advanced-stage lung cancer patients develop arterial pulmonary hypertension – DZL scientists of…